Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2001-2-2
pubmed:abstractText
To understand the impact of the menstrual cycle on immunologic parameters, we measured the level of cytokines and chemokines from plasma, cervicovaginal lavage (CVL), and saliva samples of 6 premenopausal women during the follicular and luteal phases of the ovulatory cycle. We demonstrate that the level of plasma interleukin-8 (IL-8) was 4-fold higher during the follicular phase than the luteal phase (p = 0.004), whereas plasma IL-1beta, IL-4, IL-6, IL-10, interferon-gamma (IFN-gamma), transforming growth factor-beta (TGF-beta), tumor necrosis factor-alpha (TNF-alpha), macrophage inflammatory protein-1alpha (MIP-1alpha), and TNF receptor II (TNFR II) were not altered during the ovulatory cycle. In the vaginal compartment, as measured from CVL samples, the levels of IL-6 and IL-1beta were both 5-fold higher in the follicular than the luteal phase (p = 0.0002 and 0.03, respectively). Salivary cytokine and chemokine samples were similar when measured during the luteal and the follicular phases. Additional analysis of lymphocyte subsets for phenotypic and functional markers indicated that they were not influenced by the ovulatory cycle. Collectively, these data suggest that IL-6, IL-8, and IL-1beta are differentially regulated during the ovulatory cycle.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1079-9907
pubmed:author
pubmed:issnType
Print
pubmed:volume
20
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
719-24
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:10954915-Adolescent, pubmed-meshheading:10954915-Adult, pubmed-meshheading:10954915-Antigens, CD, pubmed-meshheading:10954915-Cervix Uteri, pubmed-meshheading:10954915-Chemokine CCL3, pubmed-meshheading:10954915-Chemokine CCL4, pubmed-meshheading:10954915-Cytokines, pubmed-meshheading:10954915-Female, pubmed-meshheading:10954915-Follicular Phase, pubmed-meshheading:10954915-Humans, pubmed-meshheading:10954915-Interleukins, pubmed-meshheading:10954915-Luteal Phase, pubmed-meshheading:10954915-Lymphocyte Activation, pubmed-meshheading:10954915-Lymphocyte Subsets, pubmed-meshheading:10954915-Macrophage Inflammatory Proteins, pubmed-meshheading:10954915-Menstrual Cycle, pubmed-meshheading:10954915-Middle Aged, pubmed-meshheading:10954915-Receptors, Tumor Necrosis Factor, pubmed-meshheading:10954915-Receptors, Tumor Necrosis Factor, Type II, pubmed-meshheading:10954915-Saliva, pubmed-meshheading:10954915-T-Lymphocyte Subsets, pubmed-meshheading:10954915-Vagina
pubmed:year
2000
pubmed:articleTitle
The impact of the ovulatory cycle on cytokine production: evaluation of systemic, cervicovaginal, and salivary compartments.
pubmed:affiliation
Department of Immunology/Microbiology, Rush-Presbyterian St. Luke's Medical Center, Chicago, IL 60612, USA. lalharth@rush.edu
pubmed:publicationType
Journal Article, In Vitro, Research Support, U.S. Gov't, P.H.S.